Research Outcomes Sample Clauses

Research Outcomes. Without limiting clauses 16.1 and 16.2, the Recipient and the Project Partners will use reasonable endeavours to ensure that the know-how, results and intellectual assets generated in the course of any testing, research or other activities undertaken pursuant to the Project (Research Outcomes) are: used for the benefit of the UK society and economy; disseminated to UK5G and the 5G Ecosystem; and published in accordance with normal academic custom and practice and the RCUK Open Access Policy. A reasonable, temporary delay in the publication or dissemination of Research Outcomes in accordance with clause 16.7 will be permitted while the Recipient takes steps to: protect any registrable Developed IPRs subsisting in the Research Outcomes; and put in place exploitation or collaboration arrangements. CONFIDENTIALITY
AutoNDA by SimpleDocs
Research Outcomes. The main purpose of this research is to support women works in STEM professionals, women and scientists working in the field of gender equality. • Snapshot on the history of women in STEM in EgyptStatistical analysis of women in STEM • Role models of women in STEM in the past 30 years. • Opportunities and support system for women in STEM in Egypt.
Research Outcomes. Although nowadays a great part of the collaborative research can be done remotely, sometimes the every-day workload results in a continuous postponement of the virtual partnerships. In this sense, the meetings carried out during the mobility promoted finishing two on-going scientific publications dealing with the storm climate along the Gulf of Cadiz and its relation with coastal hazards [4,5]. Furthermore, the establishment of new collaborations within the host lecturer research network also lead to the publication of two scientific papers on the Gulf of Cadiz circulation system [6,7] and to future publications currently under preparation. As a conclusion, it should be mentioned that the ERASMUS+ mobility has led to an improvement of the Physical Oceanography state-of-the-art in the Gulf of Cadiz. As a continuation of the above research collaboration a number of common project proposals are under preparation for different calls.

Related to Research Outcomes

  • Research Project 3.1 These Materials and Data will be used by Recipient's PI solely in connection with the Research Project, as named and described in the attached research application (insert Research Project name below):

  • Research Support opioid abatement research that may include, but is not limited to, the following:

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Outcomes Secondary: Career pathway students will: have career goals designated on SEOP, earn concurrent college credit while in high school, achieve a state competency certificate and while completing high school graduation requirements.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • For Product Development Projects and Project Demonstrations  Published documents, including date, title, and periodical name.  Estimated or actual energy and cost savings, and estimated statewide energy savings once market potential has been realized. Identify all assumptions used in the estimates.  Greenhouse gas and criteria emissions reductions.  Other non-energy benefits such as reliability, public safety, lower operational cost, environmental improvement, indoor environmental quality, and societal benefits.  Data on potential job creation, market potential, economic development, and increased state revenue as a result of the project.  A discussion of project product downloads from websites, and publications in technical journals.  A comparison of project expectations and performance. Discuss whether the goals and objectives of the Agreement have been met and what improvements are needed, if any.

Time is Money Join Law Insider Premium to draft better contracts faster.